B of A Securities Maintains Buy on CVS Health, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 66.9%

Neg 0% Neu 0% Pos 66.9%

B of A Securities analyst Allen Lutz maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $100 to $110.